Delivery Order SPE2DE24D0021-SPE2D625F8EL4
- Not listed
- Fisher Scientific Company L.L.C. was awarded a delivery order contract on September 15, 2025, valued at $1,679.64 for the procurement of Streptex Streptococcus Group A, B, C, D, and F latex agglutination kits. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and is set to be completed by September 22, 2025. This award represents a child contract under a larger contracting vehicle and will be performed in Pittsburgh, Pennsylvania. The funding...
- Fisher Scientific Company L.L.C. was awarded a $3,359.28 fixed-price delivery order on December 15, 2025, for the supply of Streptex Streptococcus Group A, B, C, D, and F latex agglutination test kits. This is a child contract under a larger indefinite delivery vehicle and carries an ultimate completion date of December 22, 2025. The award was issued by the Department of Defense's Medical Supply Chain, with performance conducted at Fisher Scientific's facility in Pittsburgh, Pennsylvania. No...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,119.76 on July 23, 2025, for the supply of Streptex Strep Group A, B, C, D, F Latex Agglutination kits. This is a fixed-price delivery order with economic price adjustment provisions, with an ultimate completion date of July 30, 2025. The contract is a child award under a larger vehicle and will be performed in Pittsburgh, Pennsylvania. The award was made on an open competition basis with no set-aside designation....
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order on September 15, 2025, valued at $1,119.76 for the supply of Streptex Strep Group A, B, C, D, and F latex agglutination kits. The contract is a child award under a larger vehicle and will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of September 22, 2025. The award was made without a set-aside designation, reflecting open competition. The funding agency is identified as the Medical Supply...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,998.42 on July 16, 2025, for 50 packs of Streptex Kit to support the Medical Supply Chain, a defense-focused federal agency. The contract utilizes a fixed-price pricing structure with economic price adjustment provisions and does not employ any set-aside designations, indicating open competition. Performance will be completed in Pittsburgh, Pennsylvania, with an ultimate completion date of July 23, 2025. As a child...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,478.21 for 50 packs of Streptex Kit on June 30, 2025, with a completion date of July 8, 2025. This fixed-price contract with economic price adjustment was issued by the Medical Supply Chain, a defense-focused federal agency, with performance taking place in Pittsburgh, Pennsylvania. The award utilized open competition with no set-aside designation, reflecting Fisher Scientific's established competitive position as a major...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,119.76 on August 20, 2025, for the supply of Streptex Kit 50-packs. This fixed-price contract with economic price adjustment provisions is funded by the Defense or Civilian Medical Supply Chain agency and requires delivery to Pittsburgh, Pennsylvania by August 27, 2025. The contract was awarded through open competition with no set-aside designation, reflecting Fisher Scientific's demonstrated capability to compete...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $1,161.84 for Streptococcus testing supplies, specifically natural Strep A positive materials, with an ultimate completion date of July 21, 2025. This child contract, awarded on July 14, 2025, supports the Defense Medical Supply Chain and will be performed in Pittsburgh, PA. The award utilized open competition with no set-aside designation, reflecting Fisher Scientific's established competitive position as a...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,024.13 for 50-pack Streptex kits by the Medical Supply Chain, a defense-focused federal agency. The contract, awarded on September 4, 2025, carries a fixed-price structure with economic price adjustment provisions and is scheduled for completion by September 11, 2025. The delivery location is Pittsburgh, Pennsylvania. This award represents a child contract under a larger vehicle and was not designated as a set-aside...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,198.01 by the Defense-affiliated Medical Supply Chain on August 12, 2025, for the procurement of Streptex Kit 50 Pack supplies. The contract, which carries a fixed-price structure with economic price adjustment terms, is scheduled for ultimate completion by August 19, 2025, and will be performed in Pittsburgh, Pennsylvania. This award represents a child contract under a larger vehicle and was issued without set-aside...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F8EL4Delivery Order
Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $1,119.76 on July 23, 2025, for the procurement of Streptex Strep Group A, B, C, D, and F latex agglutination kits. This is a child contract with no set-aside designation, performed in Pittsburgh, Pennsylvania, and funded by the Defense Medical Supply Chain. The contract incorporates economic price adjustment provisions and is scheduled for completion by July 30, 2025. Fisher Scientific, a major federal supplier of laboratory and medical equipment registered in SAM.gov since 2001, regularly delivers specialized scientific and testing solutions to defense and civilian agencies. The delivery order represents a routine procurement of diagnostic reagents and supplies from a critical vendor with an established track record of supporting federal testing and laboratory initiatives. As a supplier of comprehensive laboratory products and medical equipment, Fisher Scientific's fulfillment of this order supports the Medical Supply Chain's operational requirements for streptococcal testing capabilities. The short performance timeline and modest contract value indicate this is part of ongoing replenishment activities rather than a new initiative.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/23/25 |